secwatch.observer — SEC 8-K summary
======================================

Issuer:     JUPITER NEUROSCIENCES, INC. (JUNS)
CIK:        0001679628
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001641172-25-018619
Event type: other
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jupiter Neurosciences regains Nasdaq minimum bid price compliance
-----------------------------------------------------------------

- Nasdaq confirmed compliance on July 9, 2025 after closing bid price ≥ $1.00 for 13 consecutive days (June 18 – July 8, 2025).
- Company had been notified of deficiency on March 21, 2025 with a 180-day cure period ending September 17, 2025.
- Nasdaq considers the matter closed; common stock (JUNS) continues listing on Nasdaq Capital Market.
- Jupiter is a clinical-stage pharma developing JOTROL resveratrol platform for CNS disorders and longevity products.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679628/000164117225018619/0001641172-25-018619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679628/000164117225018619/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer